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Abstract
Background: The development of diagnostic metagenomics is driven by the need for universal, culture-independent
methods for detection and characterization of pathogens to substitute the time-consuming, organism-specific, and
often culture-based laboratory procedures for epidemiological source-tracing. Some of the challenges in diagnostic
metagenomics are, that it requires a great next-generation sequencing depth and unautomated data analysis.
Results: DNA from human fecal samples spiked with 7.75 × 101−7.75 × 107 colony forming unit (CFU)/ml
Campylobacter jejuni and chicken fecal samples spiked with 1 × 102–1 × 106 CFU/g Campylobacter jejuni was
sequenced and data analysis was done by the metagenomic tools Kraken and CLARK. More hits were obtained
at higher spiking levels, however with no significant linear correlations (human samples p = 0.12, chicken samples
p = 0.10). Therefore, no definite detection limit could be determined, but the lowest spiking levels found positive
were 7.75 × 104 CFU/ml in human feces and 103 CFU/g in chicken feces. Eight human clinical fecal samples with
estimated Campylobacter infection loads from 9.2 × 104–1.0 × 109 CFU/ml were analyzed using the same
methods. It was possible to detect Campylobacter in all the clinical samples.
Conclusions: Sensitivity in diagnostic metagenomics is improving and has reached a clinically relevant level. There are
still challenges to overcome before real-time diagnostic metagenomics can replace quantitative polymerase chain
reaction (qPCR) or culture-based surveillance and diagnostics, but it is a promising new technology.
Keywords: Molecular typing, Culture independent, Next generation sequencing
Background
Culture-independent molecular methods as quantitative
polymerase chain reaction (qPCR) and Sanger sequencing
are well-established and widely used for detection of
foodborne pathogens, typically at the species level.
Bacterial isolates are needed for the further characterization
and typing below the species level, either by the use of
traditional methods or by whole genome sequencing,
which is being implemented as the routine procedure
in laboratories worldwide [1].
Shotgun metagenomics, i.e. sequencing directly from
complex samples, is relatively fast, has the potential to
provide genomic information e.g. virulence genes and
antibiotic resistance, and the potential to detect all
pathogens and mixed infections. In addition, the culture-
independency makes it possible to study hard-to-culture
and uncultivable organisms. In diagnostic metagenomics
as a subset of shotgun metagenomics, detection and
typing of pathogens are studied. Despite the potential of
diagnostic metagenomics, the method is challenged by
sample complexity, sequencing depth and data amount, as
well as differences in community composition dependent
on sample preparation and deoxyribonucleic acid (DNA)
extraction, and the challenge in assembly of whole genomes
and connection of e.g. resistance genes to organisms [2].
Diagnostic metagenomics has been investigated in
several retrospective studies using different methods for
data analysis: Campylobacter jejuni was detected in a
study of one ill person with diarrhea, using Basic Local
Alignment Search Tool (BLAST) [3]. In another metage-
nomics study, 45 fecal samples from a 2011 outbreak of
Shiga-toxigenic Escherichia coli in Germany were ana-
lyzed, using a de novo approach, an alignment approach,
and the tool Metaphlan [4].
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In diagnostic metagenomics the sample matrix has a
great influence on the accessibility of data on the patho-
gen. Due to the extensive and complex microbial com-
position, fecal samples are difficult to analyze. Unbiased
sequencing has been successfully used clinically in detec-
tion of novel viruses from comparatively low diversity
environments in the human body, such as kidney, skin,
lungs or cervix [5–7], and detection of bacteria in urine
samples [8]. However, finding pathogenic bacteria in the
gut, a microbial environment with both a high load of
commensals and a high diversity, is certainly much more
challenging, and to our knowledge only done retrospect-
ively, e.g. [3, 4].
Here we present a study of the limits and linearity in
detection of Campylobacter - the most prevalent food-
borne bacterial pathogen. First, a robust bioinformatics
analysis, including the removal of false positive hits from
phage and plasmid DNA, was developed by the use of
data sets produced from human and chicken fecal sam-
ples spiked with controlled amounts of Campylobacter
jejuni. Secondly, by the analysis of clinical samples from
patients with Campylobacter infection, the developed
analysis method was used for confirming the obtained
theoretical detection limits.
Methods
Experimental design
The laboratory work for this publication was done at
two different sites. The human samples were analyzed at
Statens Serum Institut, Denmark, and the chicken
samples were analyzed at the National Food Institute,
Technical University of Denmark. All samples were
sequenced at Statens Serum Institut. Hence, there are
minor differences between the laboratories in materials
and methods used. The experimental setup including
the most important differences and the data analysis is
seen in Fig. 1.
Human samples
A total of 22 clinical, Campylobacter culture-positive,
fecal samples were kindly provided by Bente Olesen at
the Department of Clinical Microbiology, Herlev Hospital,
Denmark. Five Campylobacter culture-negative human
fecal samples were pooled and mixed with sterile buffered
saline to obtain a pipetable and uniform consistency, and
spiked with a liquid culture of C. jejuni strain 381 in 10-
fold serial dilutions from 7.75 × 101−7.75 × 107 colony
forming units (CFU)/ml. A negative control spiked with
physiological saline was included. Spiking levels were
confirmed by triplicate plate spreading and qPCR. All
spiked samples were stored at 4 °C until DNA extraction.
DNA from the clinical samples was stored at −18 °C
for 3 years before eight samples were sequenced.
Chicken samples
Ten chicken fecal droppings of approximate 10 g each
were collected in a conventional Danish chicken house
with no known history of Campylobacter infections. The
samples were transported at 4 °C to the laboratory, and
processed within 2 hours of collection. The fecal drop-
pings were pooled upon confirmation of the absence of
Campylobacter by qPCR. Subsamples were spiked with a
liquid culture of C. jejuni strain DVI-SC181 in 10-fold
serial dilutions from 1 × 102 to 1 × 106 CFU/g. One sub-
sample was used as a negative control. Spiking levels
were confirmed by duplicate plate spreading and qPCR.
DNA extraction
DNA was extracted from spiked and clinical human
fecal samples with QIAamp Fast DNA Stool Mini Kit
(QIAGEN, Hilden, Germany) according to the manufac-
turer’s instructions for pathogen detection, however with
the following modifications: In step 14, 110 μl Buffer
ATE was used to increase DNA concentration. As start-
ing material, 200 μl of fecal sample was used. DNA was
extracted from chicken fecal samples with QIAamp Fast
DNA Stool Mini Kit (QIAGEN, Hilden, Germany) ac-
cording to the manufacturer’s instructions on pathogen
detection step 1–4 (inhibition buffer and heat treat-
ment), and on human DNA analysis step 5–14 (larger
volumes of reagents) to maximize DNA yield according
to [9]. However, in step 14, 100 μl Buffer ATE was used
to increase DNA concentration. In addition, based on
observation from other studies [10], the starting material
was standardized to 0.2 g of fecal sample. DNA was
extracted from C. jejuni strain 381 and C. jejuni strain
DVI-SC181 with QIAamp Fast DNA Stool Mini Kit
(QIAGEN, Hilden, Germany) according to the manufacturer’s
instructions on pathogen detection.
qPCR
A validated qPCR assay for thermotolerant C. jejuni, C.
coli and C. lari based on amplification of a 287 basepair
(bp) sequence of the 16S rRNA gene was performed on
a Stratagene Mx3005P (ThermoFisher Scientific, Waltham,
MA USA) for all samples in the present study [11].
Fluorescence measurements were analyzed with the
MxPro-Mx3005P software (version 4.10). The threshold
was assigned using the software option background-based
threshold; i.e., the standard deviation of all amplifications
was determined from cycle five to cycle nine, and this
value was multiplied by a background sigma multiplier of
ten [12]. Samples were analyzed in duplicate, and every
qPCR analysis included a non-template control, a negative
control (5 ng of Escherichia coli DNA), positive controls
(0.5, 0.05 and 0.005 ng of C. jejuni DNA) and intern
amplification control in all wells to avoid false negative
responses. For clinical samples infected with Campylobacter
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the standard curve calculated from spiked human samples
was used to estimate the infection load.
Library preparation and sequencing
Procedures for library preparation and sequencing were
identical for all samples. DNA was quantified with Qubit
High Sensitivity kit (ThermoFisher Scientific, Waltham,
MA, USA), and libraries for sequencing were prepared
using the Nextera XT DNA Sample Preparation kit
(Illumina, San Diego, CA, USA) according to the manufac-
turer’s protocol. Paired-end sequencing with 2 × 250 bp
was done on Illumina MiSeq (Illumina, San Diego, CA,
USA) using V2 Chemistry. The eight spiked human
samples were multiplexed and sequenced together on one
flow cell, the six spiked chicken samples were multiplexed
and sequenced together on one flow cell, and the eight
clinical samples were multiplexed and sequenced together
on one flow cell.
DNA from C. jejuni strain 381 and C. jejuni strain
DVI-SC181 was paired-end sequenced with 2 × 150 bp
multiplexed with 16 bacterial isolates not included in the
present study, and sequenced on one flow cell.
Human Chicken
Sample collection Composite of 5 stool samples 10 fecal droppings
Confirmation on
absense of
Campylobacter
Cultivation
Spiking organisms Campylobacter jejuni strain 381 Campylobacter jejuni strain DVI-SC181
Spiking levels 1×102-1×106 CFU/g + negative control7.75×101-7.75×107 CFU/ml 
+ negative control
Confirmation on
spiking levels
Triplicate plate spreading
+ real-time PCR
Dublicate plate spreading
+ real-time PCR
DNA extraction QIAamp Fast DNA Stool Mini Kit with
minor adjustments
QIAamp Fast DNA Stool Mini Kit with
adjustments
Library preparation Nextera XT DNA Sample Preparation Kit
Illumina MiSeq paired-end sequencing 2×250 bpSequencing
Data analysis
Quality trimming
Downsampling
Kraken analysis Analysis of total 
bacterial composition
Extract reads assigned to Campylobacter
Extrac thigh-scoring reads for which
1 − > 0.5
Remove reads
matching plasmid or
phage DNA by Kraken
Real-time PCR
Remove reads
matching plasmid or
phage DNA by BLAST
Remove reads matching
plasmid or phage DNA by
Kraken and BLAST
Fig. 1 Study design. Flowchart showing workflow in the study and differences between the analysis of human and chicken samples
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Data analysis
Reads were trimmed and samples downsized using
Mothur v.1.31.2 [13]. Reads were trimmed to a mini-
mum length of 50 bp, an average quality of 25 in a slid-
ing window of 50 bases and a minimum quality of the
single bases of 10. Reads containing ambiguous bases
were removed. Samples were downsized for all samples
in a data set to contain the same number of reads as the
sample in the set with the fewest reads.
Based on preliminary studies (data not shown) we de-
cided to analyze the data thoroughly using a combin-
ation of Kraken [14] and nucleotide BLAST [15]. Kraken
is a metagenomic sequence classifier based on exact align-
ment of k-mers. The Kraken database contains k-mers
and corresponding lowest common ancestors. Sequences
without matching k-mers in the database are left as un-
classified. We analyzed our data using default settings and
the standard bacterial database. For comparisons, data
were also analyzed by CLARK [16] using the same data-
base as for Kraken and classifying at genus level. After-
wards CLARK hits were analyzed by BLAST and hits to
phages and plasmids were removed. For all BLAST ana-
lyses we used an e-value cutoff of 10−60. Contigs from
C. jejuni strain 381 and C. jejuni strain DVI-SC181 were
assembled using CLC Genomic Workbench (QIAGEN
Bioinformatics, Aarhus, Denmark), and the genomes were
added to the Kraken database. The database was down-
loaded March 2014.
Based on Kraken reports we extracted all reads assigned
to Campylobacter. These reads were given a score be-
tween 0 and 1 calculated as Campylobacter kmersall kmers 
1− unassigned kmersall kmers
 
. Reads with a score above 0.5 were fur-
ther analyzed. Hits to plasmids and phages were discarded
first by Kraken using the standard bacterial database and
then by BLAST using all plasmid and phage sequences
available from Genbank in beginning of July 2015 [17].
Only hits to chromosomal DNA were kept and considered
as positive hits. For clinical samples, hits with only one
BLAST reference were removed before removal of hits to
plasmids and phages by BLAST. Simple linear regressions
correlating log transformed spiking levels and log trans-
formed final number of Kraken hits were made.
Rarefaction curves of the mean species richness were
created based on Kraken reports on down sampled data.
The total bacterial composition was described in histo-
grams. Reads identified to phylum level were included in
the analysis, whereas unclassified reads and reads only
identified above phylum level were left out. All phyla
which made up at least 1% of the total bacteria were
assigned their own category, the remaining phyla were
collected in the category “other assigned”.
Results
qPCR, sequencing and data quality
The quality of qPCR results, sequencings and data qual-
ity was high enough to support our analyses (Table 1).
qPCR efficiency was at the same level for the human
and chicken spiking series and clinical samples and all
unspiked samples were qPCR negative. MiSeq sequenc-
ings yielded cluster densities from 991 to 1326 clusters/
mm2. Number of reads in datasets after quality trimming
varied from 2.74 to 8.47 million reads, with average read
lengths from 172 to 232 bases. All dataset were down-
sized so each sample in a data set contained the same
number of reads. The assembly of spiking organisms
was of sufficient quality for both organisms.
Data analysis of human clinical samples
Results from data analysis of clinical samples including
infection load determined by qPCR, Kraken hits before
and after filtering, and CLARK hits before and after
filtering are shown in Table 2.
The clinical samples had estimated infection loads
between 9.2 × 104 and 1.0 × 109 CFU/ml. It was possible
Table 1 Quality of results
Human fecal samples Chicken fecal samples Clinical fecal samples
qPCR r2 0.993 0.939 0.996
efficiency 78.3% 79.8% 104%
Whole genome sequencing
of spiking organisms
Genomic coverage of assembly 40.2× 113.8× N/A
N50 221,548 177,674 N/A
Number of contigs 281 67 N/A
MiSeq sequencing Cluster density (clusters/mm2) 991 1198 1326
Data quality after trimming Number of reads (billions) 2.96–5.57 4.27–8.47 2.74–6.20
Minimum read length 50 50 50
Maximum read length 251 251 251
Average read length 217–229 193–232 172–206
Data set size after down sampling Number of reads (billions) 2.96 4.27 2.74
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to detect Campylobacter in all samples as they were all
positive in both Kraken final and CLARK final. Seven of
the samples contained 0.10–1.26% human DNA whereas
the last sample contained much more, 37.59%.
Data analysis of spiked samples
Results from data analysis of spiked samples including
Kraken hits before and after filtering and CLARK hits
before and after filtering are shown in Table 3.
Higher spiking levels generated more hits to Campylo-
bacter, but the number of hits was not proportional to
spiking level. The raw Kraken and CLARK analyses
showed that there was a “background level” of false posi-
tives in all samples including samples not spiked and be-
ing qPCR negative. Removal of phage and plasmid DNA
reduced the number of false positives markedly, although
it was not sufficient to remove all hits in unspiked sam-
ples. All spiked human samples contained 0.02% human
DNA corresponding to 3541–4064 reads. Chicken sam-
ples contained 0.04–0.07% chicken DNA corresponding
to 1737–3101 reads.
Detection limits were based on Kraken final hits. For
human samples, the unspiked sample was negative as
were the samples spiked with 7.75 × 101, 7.75 × 102,
7.75 × 103, and 7.75 × 105 CFU/ml. The positive sam-
ple with lowest spiking level was spiked with
7.75 × 104 CFU/ml, which can be seen as a “best case”
detection level. A worst case detection limit would be
7.75 × 106 CFU/ml, as all samples with higher spiking
levels were positive. For chicken samples, the positive
sample with the lowest spiking level was spiked with
1 × 103 CFU/g and had two hits. As all samples with
higher spiking levels were positive 1 × 103 CFU/g can
be seen as a best case detection limit. However, the
negative sample also had two hits, which makes
1 × 104 CFU/g the worst case detection limit.
Linearity was investigated using simple linear regres-
sions correlating log transformed spiking levels and log
transformed final number of Kraken hits. For human
samples with hits above the best case detection limit
(n = 3), there were no linear correlation between the
number of hits and the corresponding spiking levels
(p = 0.12). For chicken samples above the best case de-
tection limit (n = 4), there were no linear correlation be-
tween the number of hits and the corresponding spiking
levels (p = 0.10).
Figure 2 shows rarefaction curves for human clinical
fecal samples (a), spiked human fecal samples (b) and
spiked chicken fecal samples (c). On curves for spiked
samples all the subsamples are very close to each other.
The curve for chicken samples flatten more of than that
for human samples, showing that the chicken subsam-
ples represent the total community a bit better than the
human subsamples. The curves for clinical samples are
more different. The curves flatten most for the samples
1 and 38 and least for the samples 14, 24 and 39.
Analyses of the total bacterial composition (Fig. 3)
were based on the Kraken reports. For human feces
approximately 40% of the reads were classified and the
main phyla were Bacteroidetes and Firmicutes. For
Table 2 Data analysis of clinical samples
Infection load (CFU/ml) Kraken raw Kraken final CLARK raw CLARK final Host contamination %
9.2 × 104 757 10 155 81 0.72
5.0 × 106 1940 295 932 159 1.26
2.2 × 107 5129 848 5034 3126 0.10
2.6 × 107 3917 565 3667 2170 0.27
1.0 × 108 3286 362 3122 2048 0.18
2.0 × 108 42,412 20 5625 4146 37.59
4.6 × 108 13,288 2609 13,141 9787 0.12
1.0 × 109 199,512 3439 199,219 14,872 0.15
Table 3 Data analysis of spiked samples
Spiking level Kraken raw Kraken final CLARK raw CLARK final
Human samples
0 218 0 198 15
7.75 × 101 134 0 128 6
7.75 × 102 168 0 152 8
7.75 × 103 212 0 195 12
7.75 × 104 203 4 187 15
7.75 × 105 172 0 148 8
7.75 × 106 238 50 227 73
7.75 × 107 1097 615 1043 703
Chicken samples
0 234 2 184 12
1 × 102 256 0 229 12
1 × 103 217 2 183 11
1 × 104 794 423 760 531
1 × 105 569 222 536 290
1 × 106 5976 4141 5923 5018
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chicken feces approximately half of the reads were clas-
sified and the main phyla were Proteobacteria, Firmi-
cutes and Bacteroidetes.
Discussion
There are three main findings in the present study: First,
it was possible to detect Campylobacter in eight human
clinical fecal samples with estimated infection loads of
9.2 × 104–1.0 × 109 CFU/ml. Second, based on spiked
human fecal samples, a best case detection limit was set
to 7.75 × 104 CFU/ml and a worst case detection limit
was set to 7.75 × 106 CFU/ml. Based on spiked chicken
fecal samples, a best case detection limit was set to
1 × 103 CFU/g and a worst case detection limit was set
to 1 × 104 CFU/g. Finally, false positive hits in unspiked,
qPCR-negative samples were markedly reduced or com-
pletely removed by removal of phage and plasmid DNA.
The infection load in the clinical samples varied with a
factor of 104. This is a great span and still we were able
to convincingly detect Campylobacter in all samples.
The optimistic detection limit is just below the lowest
clinical infection load, making it reliable that this is actu-
ally the true detection limit, although the sample spiked
with 7.75 × 105 CFU/ml has no Kraken final hits. We
have no explanation why this sample has not final Kra-
ken hits, as it is qPCR positive with a Ct-value that fits
well with the other samples in the spiking series.
The detection limits for human and chicken fecal sam-
ples were quite different. This may be because the hu-
man intestinal bacterial community is more diverse or
because human feces contain a higher number of bac-
teria per gram of feces. A third possibility is, that we see
this difference due to down sampling, as the human
samples were down sampled to 2.96 billion reads and
the chicken samples to 4.27 billion reads. The rarefac-
tion curves in Fig. 2 show that the down sampled
chicken samples describe the bacterial diversity a bit bet-
ter than the down sampled human samples. However,
this sequencing depth was enough to detect Campylo-
bacter in all clinical samples which were down sampled
to 2.74 billion reads. To gain the same sensitivity as
qPCR approximately ten times more data from each
sample is needed for both matrices.
Despite the same fecal matrix was used for spiking
throughout a spiking series, the fraction of reads pos-
sible to assign and the bacterial composition on phylum
level varied more than expected among the spiking
levels. However, all the samples in a spiking series were
very similar in the rarefaction curves. Probably the
Fig. 2 Rarefaction curves of the mean species richness for each
subsample. Horizontal axes hold individuals in subsample and vertical
axes hold mean species richness. a human clinical fecal samples, b
human spiked fecal samples, c chicken spiked fecal samples
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observed variation in background is due to the nature of
next-generation sequencing techniques.
In the present study it was not possible to find a linear
correlation between spiking level and reads originating
from the spiking organism. If higher spiking levels had
been included in the study it might have been possible
to find a linear correlation, as the hits in the two highest
spiking levels in each spiking series differed with a factor
10, as the spiking did. It is unknown why we do not see
this linearity, but it may be due to the non-linear nature
of metagenomic data [18], which should rather not be
down sampled and instead be modelled as a mixture dis-
tribution. With the consistent background of the spiked
samples, the non-linearity of detected spiked reads is
troubling.
Host contamination was not considered a problem for
the spiked samples, as it comprised a very small part of
the DNA. This was also true for most of the clinical
samples, except the one with a host contamination of
38%. For this sample the host contamination may have
influenced the result of the analysis of bacterial content,
as the host DNA was not removed from the data neither
before nor after the down sampling. In future studies of
clinical samples it may be recommendable to remove
host DNA before analyzing the bacterial DNA.
When interpreting our results from the data analysis it
became clear, that some hits were false positives, be-
cause Campylobacter was detected in high numbers in
samples that were not spiked qPCR negative. We were
able to remove these false positive hits in the Kraken
analysis, and to reduce them in the CLARK analysis. In
general the raw Kraken and CLARK results were in
agreement with each other for all three dataset. The raw
Kraken analysis was improved by scoring hits and re-
moval of phages and plasmids by Kraken and BLAST.
This removal of false positive hits substantially improved
the confidence in the Kraken final results. The CLARK
analysis was only improved by removal of phages and
plasmids by BLAST, and this was not enough to remove
all false positive hits. This makes it clear, that it is
important to be familiar with the tools chosen for data
analysis, and that it may be necessary to adjust or add to
these tools.
Conclusions
The sensitivity of diagnostic metagenomics is improving
and has reached a clinically relevant level. For diagnostic
metagenomics to become useful in surveillance and
diagnostics of food borne diseases it is important to
continuously improve reliable and robust bioinformatic
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tools for data analysis. While we at present do not
recommend replacing current qPCR or culture-based
surveillance and diagnostic programs, the present study is
a step in that direction.
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